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a  b  s  t  r  a  c  t
Relatively  little  is known  about  the  neuropathophysiology  of binge-eating  disorder  (BED).  Here,  the  evi-
dence from  neuroimaging,  neurocognitive,  genetics,  and  animal  studies  are  reviewed  to  synthesize  our
current  understanding  of  the  pathophysiology  of BED.  Binge-eating  disorder  may  be conceptualized  as  an
impulsive/compulsive  disorder,  with  altered  reward  sensitivity  and  food-related  attentional  biases.  Neu-
roimaging  studies  suggest  there  are  corticostriatal  circuitry  alterations  in  BED  similar  to  those  observed
in  substance  abuse,  including  altered  function  of  prefrontal,  insular,  and  orbitofrontal  cortices  and  the
striatum.  Human  genetics  and  animal  studies  suggest  that  there  are  changes  in neurotransmitter  net-
works,  including  dopaminergic  and  opioidergic  systems,  associated  with  binge-eating  behaviors.  Overall,eward
euroimaging
ompulsivity
mpulsivity
the current  evidence  suggests  that  BED  may  be  related  to  maladaptation  of the  corticostriatal  circuitry
regulating  motivation  and  impulse  control  similar  to  that  found  in other  impulsive/compulsive  disor-
ders.  Further  studies  are  needed  to understand  the genetics  of  BED  and how  neurotransmitter  activity
and  neurocircuitry  function  are  altered  in  BED  and  how  pharmacotherapies  may  inﬂuence  these  systems
to  reduce  BED  symptoms.
©  2016  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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. Introduction
Binge-eating disorder (BED) is the most prevalent eating disor-
er (Hudson et al., 2007; Kessler et al., 2013) and is now included in
he main section of the Diagnostic and Statistical Manual of Mental
isorders, Fifth Edition (DSM-5) (American Psychiatric Association,
013). Despite its high prevalence, the etiology of BED remains
nderstudied, and the underlying neurobiological features of the
isorder are poorly understood (Schienle et al., 2009). This arti-
le reviews human neuroimaging, neurocognitive and genetic BED
ata (Table 1) and considers complementary animal data relating
o binge eating. Data suggest that compared with individuals with-
ut BED (hereafter referred to as non-BED), individuals with BED
ave greater cognitive attentional biases towards food, decreased
eward sensitivities, and altered brain activation in regions asso-
iated with impulsivity and compulsivity. It is worth noting at the
utset of this review that the concept “food addiction” is an ongoing
rea of research, with several recent reviews addressing this topic in
elation to obesity and eating disorders in great detail (Hebebrand
t al., 2014; Meule, 2015; Meule and Gearhardt, 2014; Potenza and
rilo, 2014). Furthermore, available evidence suggests stress and
motional regulation may  play a role in BED (Corwin et al., 2011;
ianini et al., 2013; Gluck et al., 2004; Hilbert et al., 2011; Laessle
nd Schulz, 2009; Larsen et al., 2009; Nicholls et al., 2016; Pendleton
t al., 2001; Pinaquy et al., 2003; Rosenberg et al., 2013; Schulz and
aessle, 2012). However, as these models are not the main focus of
his review, they are only brieﬂy discussed.
. Impulsivity-related constructs and other cognitive
unctions
.1. Impulsivity and compulsivity
Impulsivity reﬂects decision-making occurring with limited
orethought and represents a multidimensional construct involv-
ng tendencies to act rashly, to have increased reward-related
rives, and to have disadvantageous decision-making (Dawe and
oxton, 2004). In contrast, compulsivity is characterized by the
erformance of repetitive and persistent actions that are not
elated to an overall goal or reward and that can persist despite
dverse consequences (Dalley et al., 2011). Increased impulsivity,
levated compulsivity, and altered reward sensitivity/punishment
re reported in BED (Carrard et al., 2012; Duchesne et al., 2010;
alanti et al., 2007; Manwaring et al., 2011; Schag et al., 2013; Wu
t al., 2014; Wu et al., 2013). Compared with non-BED obese and
ormal weight individuals, those with BED have increased impul-
ivity scores on the Barratt (BIS-11) and UPPS impulsiveness scales,
ecreased self-control, and impaired set-shifting reﬂective of per-
everative/compulsive behaviors (Danner et al., 2012; Duchesne
t al., 2010; Fineberg et al., 2014; Galanti et al., 2007; Hege et al.,
015; Manwaring et al., 2011; Schag et al., 2013; Wu  et al., 2014;
u et al., 2013). Impulsivity may  underlie the diminished control
bserved during binge-eating episodes in BED, as higher BIS-11
cores were correlated with larger test meal intake (Galanti et al.,
007). Altered reward sensitivity is observed in overweight/obese
and low self-esteem in individuals with BED are associated with
greater impulsivity and sensitivity to punishment (Carrard et al.,
2012). Taken together, the behavioral alterations observed in BED
individuals indicate that BED may  be conceptualized as an impul-
sive/compulsive disorder.
2.2. Other cognitive functions
Cognitive deﬁcits in executive function, inhibitory control,
attention, and mental ﬂexibility are also reported in individu-
als with BED (Boeka and Lokken, 2011; Duchesne et al., 2010;
Mobbs et al., 2011). Obese BED individuals exhibit broad cognitive
dysfunction compared with obese non-BED individuals on tasks
assessing problem solving, plan formulation and implementation,
task scheduling, performance monitoring, cognitive ﬂexibility, and
working memory (Duchesne et al., 2010). Obese BED individuals
also perform worse than obese non-BED individuals in multi-
ple behavioral-tendency domains (apathy, disinhibition, executive
dysfunction) related to prefrontal cortical function (Boeka and
Lokken, 2011). While obese BED individuals exhibited impaired
inhibitory control, attention, and rates of learning compared with
obese non-BED individuals, BED and non-BED obese individuals
performed worse than normal-weight individuals, suggesting that
obesity alone may  be related to impaired functioning (Mobbs et al.,
2011).
2.2.1. Food-related attentional and memory biases
Individuals with BED have been shown to exhibit altered atten-
tional and memory biases regarding food-related cues, and to a
lesser extent, body-image-related cues (Schmitz et al., 2014; Svaldi
et al., 2010a, 2014). Overweight women with BED preferentially
attended to food-related stimuli compared with overweight non-
BED women, including faster identiﬁcation of visually obscured
food-related words than non-food-related words and a faster
ﬁxation on a spatial cue located in the same vicinity as a food-
related image (Schmitz et al., 2014). Overweight individuals with
BED showed more cognitive interference during performance of
a working-memory task than those without BED, regardless of
whether the interfering cues were food-related (Svaldi et al., 2014).
However, cognitive interference in BED individuals was greater
after exposure to food-related stimuli than to neutral stimuli
and was  substantially greater compared with non-BED individu-
als when stimuli were presented in a manner representative of
everyday situations (Svaldi et al., 2014). These alterations highlight
the differential response of BED individuals to environmental cues,
particularly to cues related to food.
2.2.2. Decision-making impairment
Decision-making impairments may  also be associated with BED.
In a probabilistic-reward task, individuals with BED made riskier
decisions than non-BED individuals (Svaldi et al., 2010b). Obese
individuals with BED also showed reduced preference for delayed
rewards and probabilistic rewards compared with obese non-
BED individuals and normal-weight individuals, suggesting that
impaired decision-making may  relate in part to impatience and riskED individuals, as shown by gazing longer at food-related cues
uring a visual saccade task, with BED individuals having more
ifﬁculty inhibiting saccades toward both food- and non-food-
elated stimuli (Schag et al., 2013). Comorbid depressive symptomsaversion (Manwaring et al., 2011). BED-related decision-making
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Table  1
Overview of human studies of the neurobiology of BED.
Study Assessment Study design and participants Key ﬁndings
Neuroimaging studies
Balodis et al. (2013a) fMRI Obese adults with BED (n = 19), obese adults
without BED (n = 19), and normal-weight adults
(n = 19) performed a monetary incentive delay task
• There were no signiﬁcant differences on
earnings or hit rate for win trials or loss trials
between individuals with versus without BED
during performance of the task
•  Individuals with BED had decreased activity
across a range of brain regions, including
ventromedial prefrontal cortex, inferior frontal
cortex, and insular cortex, compared with obese
individuals without BED during anticipatory
reward/loss processing
Balodis et al. (2013b) fMRI Obese adults with BED (n = 11), obese adults
without BED (n = 13), and normal-weight adults
(n = 11) performed Stroop color-word interference
task
• There were no signiﬁcant group differences in
Stroop Effect test performance
• Individuals with BED had diminished activity in
the right lateral and anterior medial orbital
cortex, ventromedial prefrontal cortex, and
inferior frontal gyrus (regions associated with
inhibitory control) during the Stroop test
compared with individuals without BED and
normal-weight individuals
Balodis et al. (2014) fMRI Obese individuals with BED (N = 19) performed a
monetary incentive delay task before 4-month
treatment with sibutramine and/or CBT
• There were no signiﬁcant group differences in
monetary incentive delay task performance
between treatment nonresponders (n = 10) and
treatment responders (n = 9)
• Treatment nonresponders showed reduced
ventral striatal and inferior frontal gyrus
recruitment during the anticipatory phase of
reward processing and reduced activity in the
medial prefrontal cortex during the outcome
phase of reward processing compared with
treatment responders
Cambridge et al. (2013) fMRI Obese individuals with BED were treated with
either placebo (n = 21) or a -opioid receptor
antagonist (GSK1521498; n = 21); grip force was
measured in response to high- or low-caloric food
images and high- or low-reward nonfood images
to  ascertain the effort participants were willing to
expend to view these images
• -Opioid receptor antagonism reduced
motivation to view the high-caloric food images
compared with placebo but increased reported
liking of these images
• -Opioid receptor antagonism reduced right
pallidum/putamen activity in response to
high-caloric food images compared with placebo
Schienle et al. (2009) fMRI Women  with BED (n = 17) and normal-weight
(n = 19) and overweight (n = 17) women without
eating disorders were exposed to high-caloric food
pictures, disgust-inducing pictures, and neutral
pictures; reward sensitivity ratings were measured
with the Behavioral Inhibition/Activation Scales
• Individuals with BED reported greater reward
sensitivity than normal-weight individuals and
obese women without BED
•  Individuals with BED showed increased
activation in the medial orbitofrontal cortex,
anterior cingulate cortex, and insular cortex in
response to high-caloric food images compared
with normal-weight and obese women  without
BED; neural responses to disgust-inducing
pictures did not differ between groups
Wang et al. (2011) PET Dopaminergic activity in response to food or
neutral stimuli after treatment with oral MPH or
placebo was measured in 16-hour fasted obese
individuals with BED (n = 10) and obese individuals
without BED (n = 8)
• Food stimuli signiﬁcantly increased desire for
food only after placebo in individuals with BED
and only after MPH  in individuals without BED
•  Baseline D2-like receptor availability, as
measured by 11C-raclopride did not differ
between obese individuals with BED and obese
individuals without BED
• MPH  produced greater increases in dopamine
release in the caudate nucleus of obese
individuals with BED in response to food stimuli
than in obese individuals without BED
• Dopamine release in the caudate was correlated
with the severity of binge eating in individuals
with and without BED
Weygandt et al. (2012) fMRI Women  with BED (n = 17) and normal-weight
(n = 19) as well as overweight (n = 17) women
without eating disorders were exposed to
high-caloric food pictures, disgust-inducing
pictures, and neutral pictures; reward sensitivity
ratings were measured with the Behavioral
Inhibition/Activation Scales
• Sensitivity and speciﬁcity analyses indicated
that activity in the right insular cortex
distinguished the BED group from the
normal-weight group
• Sensitivity and speciﬁcity analyses indicated
that activity in the right ventral striatum
separated the BED group from obese women
without BED
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Table  1 (Continued)
Study Assessment Study design and participants Key ﬁndings
Tammela et al. (2003) SPECT Radioligand-labeled serotonin transporter binding
was  recorded in obese women  with BED (n = 7) and
obese women without BED (n = 6) before and after
successful treatment with combined
psychotherapy and ﬂuoxetine
• Serotonin transporter binding in the raphe
nucleus increased in symptomatically recovered
obese women  with BED but was unchanged by
treatment in obese women without BED
Karhunen et al. (2000) SPECT Obese women with BED (n = 8), obese women
without BED (n = 11), and normal-weight women
(n = 12) were exposed to a control stimulus
(landscape picture) and to a food stimulus (warm
freshly cooked lunch)
• Obese women with BED exhibited increases in
blood ﬂow in the left frontal and prefrontal
cortices in response to the food stimulus; obese
individuals without BED and normal-weight
individuals showed no change or localized
increases in the right hemisphere
Kuikka et al. (2001) SPECT Radioligand-labeled serotonin transporter binding
was  recorded in obese women with BED (n = 11)
and obese women without BED (n = 7)
• Obese women with BED showed decreased
midbrain serotonin transporter binding relative
to obese women without BED
Hege et al. (2015) MEG  Overweight/obese women with BED (n = 17) and
without BED (n = 17) were assessed on the Barratt
Impulsiveness Scale and in a food-related
“go/no-go” task
• Individuals with BED tended to score higher on
the Barratt Impulsiveness Scale; “no-go”
accuracy tended to worsen more often in
individuals with BED in response to food-related
stimuli
•  Individuals with BED did not have a
food-speciﬁc prefrontal cortical activity increase
during the “go/no-go” task
Svaldi et al. (2010c) ERP Women with BED (n = 22) and overweight women
without BED (n = 22) were exposed to high- and
low-caloric food pictures
• Individuals with BED rated high-caloric food as
more forbidden than did individuals without
BED
•  High-caloric food images, but not low-caloric
images, elicited larger and longer-lasting late
positive potentials, an index of motivated
attention, in women with BED compared with
women  without BED
Tammela et al. (2010) EEG EEG was  assessed in obese women  with BED
(n = 12) and without BED (n = 13) during a resting
state (closed eyes) and while attending to a control
landscape image or a food stimulus
• Fronto-central beta activity (14–20 Hz) was
increased in obese women  with BED during all
states (resting, control, food stimulus) relative to
obese women  without BED
•  Beta activity correlated with the disinhibition
factor scores on the Three-Factor Eating
Questionnaire and with Binge Eating Scale
scores in individuals with BED
Schafer et al. (2010) Structural
MRI
Gray-matter-volume measurements were
recorded in women with BED (n = 17) and
normal-weight women  without eating disorders
(n = 19)
• Individuals with BED had greater gray-matter
volume in the anterior cingulate cortex and the
medial orbital frontal cortex than
normal-weight individuals
Voon et al. (2015a) Structural
MRI
Voxel-based morphometry assessed brain volume,
and a 2-step sequential learning task with a
probabilistic monetary reward assessed habit
formation in obese individuals with BED and
without BED
• Obese individuals with BED (n = 32) were more
likely to use habit-based learning and show
perseveration than obese individuals without
BED (n = 31)
• Obese individuals with BED (n = 20) had smaller
left ventral striatal, lower left lateral orbital
frontal cortex, lower bilateral orbital frontal
cortex, and lower bilateral caudate volumes
than did obese individuals without BED (n = 20),
with effects in the orbital frontal cortex, caudate,
and ventral striatum no longer signiﬁcant after
accounting for habit-based learning
Genetic and heritability studies
Cellini et al. (2010) Glucocorticoid
receptor
gene
Glucocorticoid receptor gene SNPs were examined
in  individuals with BED (n = 62) and in obese
(n = 177) and normal-weight (n = 107) individuals
without eating disorders
• The GG genotype of the rs6198 polymorphism
occurred more frequently in individuals with
BED than in normal-weight controls; the
frequency of this genotype in individuals with
BED was also elevated in individuals with BED
compared with obese individuals without BED,
but the difference was not statistically
signiﬁcant
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Davis et al. (2007) DAT1
dopamine
transporter
gene
Individuals with BED (n = 32) and aged-matched
non-obese controls without BED (n = 46) were
assessed for DAT1 genotypes and for hunger after
exposure to a food stimulus after MPH
• Individuals with BED with the 9-repeat DAT1
allele (which is associated with decreased DAT
protein and increased synaptic dopamine)
showed more appetite suppression following
MPH  than controls without BED possessing the
same allele or any individual possessing the
10-repeat allele (associated with increased DAT
protein and decreased synaptic dopamine)
Davis et al. (2008) DRD2
dopamine
receptor
gene
Individuals with BED (n = 56), obese individuals
without BED (n = 51), and normal-weight
individuals without BED (n = 59) were assessed for
reward sensitivity and genotyped for a
polymorphism of a DRD2 dopamine
receptor-linked gene
• Obese individuals and individuals with BED
possessing at least 1 copy of the A1 allele of
Taq1A exhibited increased reward sensitivity
relative to normal-weight controls
Davis et al. (2009) DRD2
dopamine
receptor
and
-opioid
receptor
gene
Obese adults with BED (n = 66) and obese adults
without BED (n = 70) were genotyped for a
polymorphism of a DRD2 dopamine
receptor-linked gene and a polymorphism of the
OPRM1 -opioid receptor gene
• Obese individuals with BED were less likely than
obese individuals without BED to have the A1
allele of Taq1A and more likely to have the G
allele of OPRM1
Davis et al. (2012) DRD2
dopamine
receptor
gene
Obese adults meeting criteria for BED (n = 79) and
obese individuals not meeting criteria for BED
(n  = 152) were genotyped for a polymorphism of a
D2 dopamine receptor-linked gene
• Obese individuals with BED were more likely
than obese individuals without BED to be
homozygous for the A2 allele of Taq1A, more
likely to be homozygous for the T allele of
C957T, and less likely to carry the minor T allele
of  rs2283265
Monteleone et al.
(2006a)
5HTT 5HT
transporter
gene
Women  with BED (n = 77) and women without
eating disorders (n = 61) were genotyped for a
5HTT gene polymorphism
• Frequencies of the LL genotype and the L allele
for the 5HTTLPR polymorphism were higher in
individuals with BED compared with those
without BED
Monteleone et al.
(2006b)
BDNF gene Women  with BED (n = 84) and women without an
eating disorder (n = 121) were genotyped for allelic
variation in the BDNF gene
• There were no differences in the frequency of
the  196G/A variants between women with and
without BED
• Among women with BED, those with the 196A/A
variant had higher frequency of binge eating and
more severe binge eating ratings than those
with the 196G/A variant
Monteleone et al.
(2008a)
CLOCK gene Overweight/obese individuals with BED (n = 107),
overweight/obese individuals without BED (n = 85),
and normal-weight individuals without BED
(n  = 92) were assessed for a CLOCK gene
polymorphism (311T/C), which relates to circadian
rhythms
• Genotype and allele frequencies did not differ
between obese individuals with and without
BED
Monteleone et al.
(2008b)
FAAH gene Overweight/obese women with BED (n = 115),
overweight/obese women without BED (n = 74),
and normal-weight women  without BED (n = 110)
were assessed for a FAAH gene polymorphism
(cDNA 385C to A), which impacts the degradation
of endocannabinoids
• Genotype and allele frequencies did not differ
between obese individuals with and without
BED
Tasca et al. (2013) IGF-II
isoforms
Overweight women with BED (n = 97), overweight
women  without BED (n = 53), and normal-weight
women  without BED (n = 50) were assessed for the
IGF-II isoforms before and after group
psychotherapy
• The mature isoform of IGF-II was  signiﬁcantly
higher in obese women with BED compared
with normal-weight women without BED, but
there were no signiﬁcant differences between
obese women with and without BED
•  The BIG IGF-II isoform decreased after group
psychotherapy, but no difference was reported
between obese women with and without BED
Hudson et al. (2006) Heritability
of BED
Blinded family interviews of overweight/obese
probands with BED (n = 150) and without BED
(n = 150) and their ﬁrst-degree relatives (n = 888)
were conducted to assess the heritability of BED
• BED aggregated in families, independent of
obesity status (odds ratio: 2.2)
Javaras et al. (2008) Heritability
of BED
Structural equation modeling assessed the
heritability of BED based on family interviews of
overweight/obese probands with BED (n = 150) and
without BED (n = 150) and their ﬁrst-degree
relatives (n = 888)
• BED aggregated in families, with an estimated
heritability of 57%
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Mitchell et al. (2010) Heritability
of BED
Structural equation modeling assessed the
heritability of BED in female monozygotic twins
(n  = 614) and dizygotic twins (n = 410) who
self-reported DSM-IV BED symptoms; 32 women
met  full criteria for BED
• BED was moderately heritable, with 45% of
heritability accounted for by additive genetics,
13% by common environmental factors, and 42%
by unique environmental inﬂuences
•  Among speciﬁc BED symptoms, loss of control
over eating and distress due to binges were
found to have the highest heritability estimates
(43%)
Reichborn-Kjennerud
et al. (2004)
Heritability
of BED
Questionnaire data regarding binge eating
behavior from twins (N = 8045) from a Norwegian
twin registry were used to assess the heritability of
BED
• Additive genetic effects accounted for 41% of the
heritability of binge eating (with a feeling of loss
of control in the absence of compensatory
behavior), with individual environmental factors
accounting for 59% of the variance
Cognitive studies
Boeka and Lokken
(2011)
Executive
function
Obese individuals with BED (n = 22), obese
individuals with subthreshold BED (n = 47), and
obese individuals without BED (n = 82) were
assessed with the Frontal Systems Behavior Scale
• Obese individuals with BED and subthreshold
BED exhibited dysfunction on the apathy,
disinhibition, and executive function subscales
and on total score compared with individuals
without BED
Duchesne et al. (2010) Executive
function
Obese women with BED (n = 38) and without BED
(n = 38) were assessed on multiple measures of
executive function
• Obese individuals with BED exhibited impaired
executive function as assessed on the Digit Span
Backward, Zoo Map, Modiﬁed Six Elements,
Action Program, and Wisconsin Card Sorting
tests compared with obese individuals without
BED
Galioto et al. (2012) Executive
function,
memory,
language,
attention
Obese individuals with a past or present BED
diagnosis (n = 41) and obese individuals without
BED (n = 90) were assessed on multiple cognitive
tests
• Obese individuals with a past or present BED
diagnosis and without BED exhibited global
impairments in cognitive function, but there
were no group differences between those with
versus without BED
Mobbs et al. (2011) Attention,
inhibitory
control
Obese individuals with BED (n = 16), obese
individuals without BED (n = 16), and
normal-weight individuals (n = 16) were assessed
on a food/body-mental ﬂexibility task
• Obese individuals with BED made more errors
and omissions than obese individuals without
BED and normal-weight controls in the food and
body sections of the task, indicating impaired
attention and inhibitory control
• Obese individuals with BED exhibited less
within-session learning than obese individuals
without BED, as evidenced by omission rates
across sessions
Schag et al. (2013) Attention,
inhibitory
control
Overweight/obese individuals with BED (n = 25),
overweight/obese individuals without BED (n = 26),
and normal-weight individuals without BED
(n  = 25) were assessed for reward sensitivity and
disinhibition in response to food stimuli using
visual saccade tracking
• Individuals with BED gazed longer at food
stimuli (increased reward sensitivity) and had
more difﬁculty inhibiting saccades toward both
food and nonfood stimuli
(disinhibition/inhibitory control) than both
obese individuals without BED and
normal-weight individuals without BED
Schmitz et al. (2014) Attention,
attentional
bias
Overweight/obese women with BED (n = 27) and
overweight/obese women without BED (n = 33)
were assessed on a test of attentional vigilance in
which they identiﬁed visually obscured words
(food-related and neutral) and a spatial cueing task
(food-related and neutral images) to examine
attentional bias
• Both obese women with BED and obese women
without BED identiﬁed obscured food-related
words faster than neutral words, with the effect
was  more pronounced for those with BED
•  Response times of obese women with BED but
not obese women without BED were more rapid
in  a spatial cueing task in response to
food-related cues compared with neutral cues
Svaldi et al. (2014) Attention,
attentional
bias
Overweight individuals with BED (n = 31) and
overweight individuals without BED (n = 36)
completed an n-back working memory tasks in the
presence of interfering cues both food-related and
neutral. Participants also performed a recent-probe
task in which a set of words are presented for a
short time each trial and then after a retention an
interval, a probe stimulus is presented and the
participant is asked to classify it as to whether it
was  a member of the most recent trial’s words; the
words used could be food-related or neutral.
• Overweight individuals with BED were more
likely than those without BED to show cognitive
interference in a working memory task that
employed a highly familiar but irrelevant
stimulus regardless of whether the interfering
cues were food-related or neutral
•  Cognitive interference in individuals with BED
was  more pronounced after exposure to
food-related stimuli than to neutral stimuli and
substantially greater compared with individuals
without BED when the working memory task
employed more diverse stimuli in a manner that
may  be more representative of everyday
situations
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Svaldi et al. (2010a) Memory
bias
Overweight individuals with BED (n = 18) and
overweight individuals without BED (n = 18)
performed a memory recall test comprised of
positive body-related words, positive control
words, negative body-related words, and negative
control words
• Overweight women with BED recalled fewer
positive body-related words and fewer positive
control words than did overweight women
without BED
Danner et al. (2012) Decision-
making
Women  with BED (n = 19), obese women  without
BED (n = 18), and normal-weight women  without
BED (n = 30) were assessed on the Iowa Gambling
Task
• Obese women with BED and obese women
without BED performed worse than
normal-weight women, but obese women  with
BED did not perform worse than obese women
without BED; task performance correlated with
binge eating severity in the BED group
Davis et al. (2010) Decision-
making
Obese women with BED (n = 65), obese women
without BED (n = 73), and normal-weight women
without BED (n = 71) were tested on the Iowa
Gambling Task and a Delay Discounting measure
• Obese women with BED and obese women
without BED performed worse than
normal-weight women on both tasks but did not
differ from each other
Manwaring et al.
(2011)
Decision-
making
Obese women meeting DSM-IV criteria for BED
(n = 30), obese women without BED (n = 30), and
normal-weight women without BED (n = 30) were
assessed on decision-making using delay and
probability discounting tasks
• Across reward types, obese women with BED
showed a reduced preference for delayed
rewards and probabilistic rewards compared
with obese individuals without BED and
normal-weight controls
Svaldi et al. (2010b) Decision-
making,
cognitive
ﬂexibility
Overweight women meeting DSM-IV criteria for
BED (n = 17) and overweight women without BED
(n = 18) were assessed using the Game of Dice task
and the Trail Making Test
• Women  with BED were more likely to make
risky decisions and show impairments in
utilizing feedback processing compared with
women without BED on the Game of Dice task
• Women  with BED exhibited impaired cognitive
ﬂexibility on the Trail Making Test compared
with women  without BED, although both groups
fell within the normal performance range
Voon et al. (2015b) Decision-
making
Obese individuals with BED (n = 30), obese
individuals without BED (n = 30) and aged, and
gender matched healthy controls completed a
probabilistic decision-making task in which on
each trial they could choose a risky choice with
probabilistic likelihood of winning or losing a
monetary reward or a sure choice with a
guaranteed outcome (win or lose) of a smaller sum
• Relative to healthy controls, individuals with
BED were more likely to make risky choices for
moderate probabilities of reward (e.g., 50%) and
for low probabilities of loss
•  Relative to healthy controls, obese individuals
without BED were less likely to make risky
choices for high probabilities of reward and, like
individuals with BED, were more likely to make
risky choices for low probabilities of loss
• The probability of risky choices did not vary
with the size of the reward for individuals with
BED but decreased for increasing reward size for
healthy controls and for obese individuals
without BED
Wu et al. (2013) Decision-
making,
Overweight/obese individuals with BED (n = 54) or
without BED (n = 43) were compared on the Game
ignal
• Overweight individuals with BED did not differ
from overweight individuals without BED on
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of  Dice task and the Stop S
mpairments were further delineated in a task in which partici-
ants could choose between risky or sure monetary choices (Voon
t al., 2015b). Obese individuals with BED were more likely than
bese non-BED individuals and age- and gender-matched healthy
olunteers to make risky choices in response to moderate proba-
ilities of reward and high probabilities of loss (Voon et al., 2015b),
 decision-making pattern similar to that observed in abstinent
lcohol-dependent and abstinent stimulant-dependent individuals
ut not obese individuals (Voon et al., 2015b). Probabilities of mak-
ng risky choices did not vary with reward magnitude in individuals
ith BED, whereas they decreased with increasing reward mag-
itude in age- and gender-matched healthy volunteers and obese
on-BED individuals (Voon et al., 2015b). Thus, individuals with
ED may  exhibit impaired decision-making in situations associated
ith high risk and ambiguity whereas obese non-BED individuals
ay  be impaired more in ambiguous situations.
However, in studies of BED cognitive and decision-making
eﬁcits are not always observed in obese BED versus obese non- task either the Game of Dice decision-making task or
on  the Stop Signal inhibitory control task
BED individuals (Danner et al., 2012; Davis et al., 2010; Duchesne
et al., 2010; Galioto et al., 2012; Wu  et al., 2013). Despite the fact
that the degree of decision-making impairment on the Iowa Gam-
bling Task correlates positively with binge-eating severity among
BED individuals (Danner et al., 2012), in one study obese BED
and obese non-BED individuals exhibited similar cognitive impair-
ments across multiple domains (memory, attention, executive
function, language) (Galioto et al., 2012) and similar impairment
on the Iowa Gambling Task (Danner et al., 2012; Davis et al., 2010).
These ﬁndings suggest that binge eating behaviors in BED individ-
uals are not solely driven by alterations in cognitive function.
In summary, BED can be associated with an array of cog-
nitive alterations related to impulsivity/compulsivity, executive
function, attention, and decision making. These alterations sug-
gest that altered function in the cortex and striatum, areas whose
function plays a key role in mediating these cognitive functions
(Berridge and Kringelbach, 2008; Bromberg-Martin et al., 2010;
Everitt and Robbins, 2013; Miller and Cohen, 2001; Naqvi and
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Fig. 1. Functional MRI  images of diminished ventral striatal activation in individuals
with BED during reward anticipation and its relationship to treatment outcome*.
(A) Coronal view (y = 12) of ventral striatal regions showing a whole brain con-
trast between obese individuals with binge eating disorder (BED; n = 19) and obese
individuals without BED (OB; n = 19). (B) Map  of differences within the BED group
separating those who reported bingeing following treatment (BEpost-tx; n = 10)
contrasted with BED participants who  did not report bingeing following treatment
(NBEpost-tx; n = 9). Brain activation maps demonstrate differences in the A2 win-
ning phase (A2W; associated with the anticipation of potentially winning money).
All  contrast maps are thresholded at an uncorrected level of p < 0.05 two-tailed and
family-wise-error corrected at p < 0.05. Blue color demonstrates areas where par-
ticipants show relatively less activation. The right side of the brain is on the right.30 R.M. Kessler et al. / Neuroscience and
echara, 2010), is altered in BED individuals. Available evidence
egarding altered brain function in BED is summarized in the next
ection.
. Brain structure and function
Neurophysiologic and neuroimaging studies have identiﬁed
hanges in individuals with BED that may  partially underlie
ltered impulsivity and reward processing. Obese women  with
ED compared with non-BED obese women exhibited increased
entroparietal cortical long-latency event-related potentials (an
ndex of motivated attention) when viewing high-caloric food pic-
ures but not neutral pictures (Svaldi et al., 2010c). Increased
rontal beta-electroencephalographic activity during resting and
ctive states was observed in obese BED women compared with
bese non-BED women; increased beta activity correlated with
cores on the disinhibition factor of the Three-Factor Eating
uestionnaire and Binge-Eating Scale in obese women with BED
Tammela et al., 2010). Obese BED women also demonstrated
ncreased regional cerebral blood ﬂow in left frontal and pre-
rontal cortices in response to food stimuli, whereas non-BED
nd normal-weight women showed no change or only local-
zed increases in the right hemisphere (Karhunen et al., 2000).
ED individuals compared with obese and normal-weight non-
ED individuals exhibited increased reward responsiveness and
ncreased medial orbitofrontal cortical activity in response to high-
aloric food images, as assessed by functional magnetic resonance
maging (fMRI) (Schienle et al., 2009). Taken together, these data
uggest altered function in cortical and striatal regions is likely to
ontribute to BED.
.1. Striatum and insular cortex
Striatal and insular function has been associated with reward
ensitivity and impulsivity in BED. During exposure to high-caloric
ood images, activation in the left ventral striatum separated
ED individuals from those with bulimia nervosa (BN), with
 sensitivity of 82% and a speciﬁcity of 86%. Right ventral-
triatal activation during exposure to high-calorie food images
ifferentiated obese BED and non-BED individuals, with a sen-
itivity of 59% and a speciﬁcity of 82%; right-insular activation
ifferentiated BED individuals from obese and normal-weight
on-BED individuals, with sensitivities of 77% and 82%, respec-
ively, and speciﬁcities of 65% and 90% (Weygandt et al., 2012).
ompared with non-BED individuals, obese individuals with
ED demonstrated bilateral decreases in ventral-striatal activa-
ion during anticipation of monetary reward receipt/loss; upon
otiﬁcation of a monetary reward, obese BED individuals demon-
trated diminished insular activity compared with non-BED obese
nd normal-weight individuals (Balodis et al., 2013a). Obese
ED individuals who continued to binge eat following treat-
ent with sibutramine and/or psychotherapy had relatively
ecreased anticipation-related right ventral-striatal activation,
nticipation-related bilateral-inferior-frontal-gyral activation, and
utcome-related medial-prefrontal-cortical activation compared
ith those who did not continue to binge eat (Fig. 1). Given links
etween anticipation-related ventral-striatal activation and impul-
ivity (Balodis et al., 2012), these ﬁndings suggest possible links
etween reward-related brain activations, impulsivity, and treat-
ent outcome in BED.
.2. Prefrontal cortex and impulse-control networksAltered cognitive function in BED may  relate to reward sensitiv-
ty (Balodis et al., 2013b; Schafer et al., 2010; Voon et al., 2015a).
uring fMRI Stroop performance, obese BED individuals showed*Unpublished data obtained from Iris Balodis and Marc Potenza; see Balodis et al.
(2014) for study description.
diminished activity in impulse control-related cortical areas (i.e.,
ventromedial-prefrontal, inferior-frontal, and insular) compared
with non-BED individuals in the absence of differences in task
performance (Balodis et al., 2013b). During a habitual learning
test, BED individuals were more likely than non-BED individu-
als to use habitual learning strategies and to show perseveration,
with obese BED versus non-BED individuals demonstrating smaller
left-ventral-striatal, bilateral-caudate, and orbital-frontal-cortical
volumes (Voon et al., 2015a). However, when behavior was  covar-
ied, group differences in the medial orbitofrontal cortex, caudate,
and ventral striatum were no longer signiﬁcant, suggesting that
individual differences in learning bias may  be related to these
ﬁndings (Voon et al., 2015a). Increased attentional impulsiveness
measured on the BIS-ll was  related to decreased response inhi-
bition in a visual go-nogo task and to hypoactivity in prefrontal
networks in obese BED and non-BED individuals, with BED indi-
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iduals exhibiting higher attentional impulsiveness scores and a
rend towards worse performance in response to food-speciﬁc
timuli than non-BED individuals (Hege et al., 2015). Results from
 pilot study suggest that the level of hypoactivity in frontal cor-
ical reward circuitry in BED relates to treatment response, with
hose with greater hypoactivity exhibiting persistent bingeing fol-
owing treatment (Balodis et al., 2014). Structural MRI  has revealed
ifferences in gray-matter volumes in the anterior-cingulate and
edial-orbitofrontal cortices in BED individuals (Schafer et al.,
010) and selective atrophy in the right striatum, right ventral-
nsular cortex, and right orbitofrontal cortex (Woolley et al., 2007)
n individuals with frontotemporal dementia who  develop binge-
ating behaviors. The precise clinical relevance of these ﬁndings
emains to be determined. However, given the preponderance of
vidence, it seems reasonable to hypothesize that altered cortical
unction contributes signiﬁcantly to the altered reward sensitivity
nd impulsivity observed in BED individuals.
. Genetics
BED aggregates in families (Hudson et al., 2006); heritability
stimates for BED range from 41% to 57% (Javaras et al., 2008;
itchell et al., 2010; Reichborn-Kjennerud et al., 2004). As with
ost psychiatric disorders, the genetics of BED are likely to be
omplex and involve interactions with environmental factors (see
able 1 for descriptions of genetics studies). Therefore, multiple
enetic studies have assessed potential substrates that might con-
ribute to the neurobiologic alterations in BED.
.1. Dopaminergic- and opioidergic-associated genetic
olymorphisms
Compared with normal-weight non-BED individuals, obese BED
nd non-BED individuals have displayed elevated reward sensitiv-
ty if they carry ≥1 copy of the A1 allele of the Taq1A polymorphism
Davis et al., 2008). This polymorphism is downstream of the DRD2
ene and is located within the ANKK1 gene (Neville et al., 2004);
t is associated with reduced D2-like receptor density in healthy
olunteers (Jonsson et al., 1999; Pohjalainen et al., 1998) and in
lcohol-dependent individuals (Yang et al., 2007). The allelic fre-
uency of A1 is lower among obese BED individuals compared with
bese non-BED individuals (Davis et al., 2009, 2012). The A2 allele of
he Taq1A polymorphism (known as rs1800497), which is associ-
ted with increased dopamine signaling (Noble et al., 1991), and
he rs6277 polymorphism of the DRD2 gene (known as C957T),
hich is associated with increased D2-like receptor binding in
11C]raclopride studies (Hirvonen et al., 2004), are more common
n obese BED individuals than in obese non-BED individuals (Davis
t al., 2009; Davis et al., 2012). BED individuals with a copy of the
-repeat allele of the dopamine transporter gene (DAT1), which
s associated with decreased dopamine levels of transporter pro-
ein and increased levels of synaptic dopamine, exhibited more
ethylphenidate-induced appetite suppression than BED individ-
als who were homozygous for the 10-repeat allele and non-BED
ndividuals regardless of genotype (Davis et al., 2007).
The “gain of function” G allele (known as G+) of the A118G poly-
orphism of the -opioid-receptor-encoding gene appears more
ommon in obese individuals with BED than in obese non-BED
ndividuals (Davis et al., 2009). The higher frequency of Taq1A
2/A118G G+ genotypes observed in BED individuals suggests that
hese individuals may  be prone to elevated food-related hedo-
ic responses through dopaminergic and opioidergic inﬂuences on
eward-related processes (Davis et al., 2009).
All of these studies are interesting, but they involved relatively
mall samples (Table 1). While replication studies are requiredavioral Reviews 63 (2016) 223–238 231
to substantiate these ﬁndings, the evidence to date supports the
concept that BED has genetic underpinnings that include altered
dopaminergic systems that may  contribute to impulsivity, com-
pulsivity, and reward/reinforcement (Avena and Bocarsly, 2012;
Buckholtz et al., 2010; Kenny et al., 2013; Nakanishi et al., 2014).
4.2. Other polymorphisms
In addition to dopaminergic and opioidergic genes, serotonergic,
glucocorticoid, brain-derived-neurotrophic-factor, CLOCK,  endo-
cannabinoid, and insulin-like-growth-factor-2 genes have been
investigated (Cellini et al., 2010; Kuikka et al., 2001; Monteleone
et al., 2006a, 2008a,b, 2006b; Tammela et al., 2003; Tasca et al.,
2013); however, results have either been equivocal or suggested
no association with BED. Although there are no published genome-
wide association studies in BED, a study comparing individuals
with bipolar disorder who  either exhibited or did not exhibit
binge-eating behaviors reported multiple single-nucleotide poly-
morphisms in association with binge-eating behaviors (Winham
et al., 2014). As with all genetic association studies, it remains
possible that the implicated genes are more related to speciﬁc
disorder-associated domains (e.g., impulsivity, compulsivity, or
reward sensitivity) rather than the disorder as a whole.
5. Translational considerations: animal and human data
BED is characterized by impulsive and compulsive consumption
of highly palatable foods, which is regulated by brain reward sys-
tems (Avena and Bocarsly, 2012; Avena et al., 2008; Mathes et al.,
2009). Although multiple neurotransmitter systems (including
dopaminergic, cholinergic, noradrenergic, opioidergic, GABAergic,
and glutamatergic systems) may  contribute to binge-eating behav-
iors, dopaminergic and opioidergic neurotransmission appear
critical to reward, including reward-related food consumption
(Avena and Bocarsly, 2012; Avena et al., 2008; Bello et al., 2014;
DiFeliceantonio et al., 2012; Mathes et al., 2009). Dopaminer-
gic neurotransmission in the nucleus accumbens/ventral striatum
(NAc) is linked to motivational and energy-dependent aspects of
food seeking and opioidergic neurotransmission is involved in
hedonic aspects of reward (Castro and Berridge, 2014; Salamone
et al., 2003; Wise, 2008). Although the reduction in food con-
sumption in animal models (Nathan and Bullmore, 2009) and the
reduction in the motivation to view high-caloric food images in
BED individuals (Cambridge et al., 2013) that occurs following
the blockade of -opioid receptors suggest that opioid systems
contribute to BED, treatment with -opioid receptor antagonists
does not reduce binge eating in BED individuals (McElroy et al.,
2013; Ziauddeen et al., 2013). While food is a natural reward,
data suggest that similar changes in dopaminergic neurotransmis-
sion in brain reward circuitry may  underlie binge-eating behaviors
(Furlong et al., 2014) and drug abuse (Everitt and Robbins, 2013).
These changes in dopaminergic neurotransmission may  contribute
to increased impulsivity, compulsive behaviors, and altered reward
sensitivity seen in these disorders (Blum et al., 2014; Everitt and
Robbins, 2013; Fineberg et al., 2014; Richard et al., 2013; Stice et al.,
2013).
5.1. Ventral midbrain-nucleus accumbens (NAc) dopaminergic
pathways
Increased impulsivity has been associated with altered
dopaminergic neurotransmission in the ventral midbrain and
NAc. Studies in animals and healthy humans have reported that
increased impulsivity is correlated with decreased ventral-striatal
and ventral-midbrain dopamine D2-like receptor levels and with
increased dopamine release in the anterior caudate and NAc
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Belin et al., 2008; Buckholtz et al., 2010). Pathway analysis sug-
ests increased dopamine release in the NAc and anterior caudate
bserved with increased impulsivity is mediated by decreased
entral-midbrain dopamine D2-like receptor levels, with these
eceptors being autoreceptors on dopamine neurons regulating
opaminergic neuronal ﬁring (Buckholtz et al., 2010). In pri-
ates, initial rates of cocaine self-administration and acquisition
f cocaine self-administration have been correlated with decreased
Ac/striatal dopamine D2-like receptor levels (Nader et al., 2008).
herefore, impulsivity may  represent a critical risk factor for
ubstance abuse, and this may  be linked to altered dopamine D2-
utoreceptor regulation of ventral-midbrain dopamine neurons,
eading to increased dopamine neurotransmission in the NAc.
Studies in rodents indicate that the development of compul-
ive drug abuse and binge-eating reﬂect progressive changes in
he locus of dopaminergic control of drug and food consump-
ion from a reward/ventral-striatal mode of consumption to a
oal-directed/posterior dorsomedial striatal mode to a chronic
abitual/compulsive mode involving anterior dorsolateral stri-
tal dopaminergic neurotransmission (Everitt and Robbins, 2013;
urlong et al., 2014; Murray et al., 2012). In primates, there is
 similar evolution of cocaine-induced decrements in both stri-
tal function and dopaminergic neurotransmission, particularly
ecrements in dopamine D2-like receptor levels (Nader et al.,
008; Porrino et al., 2004). In humans with substance addic-
ion, as well as in animal models of compulsive drug and food
ntake/binge-eating, there are decreased striatal dopamine D2-
ike receptor levels, decreased striatal dopaminergic release, and
ncreased reward thresholds (Avena, 2010; Johnson and Kenny,
010; Lee et al., 2009; Martinez et al., 2012; Volkow et al., 1993;
olkow et al., 1996). Decreased striatal dopamine D2-like receptor
evels have been inversely correlated with impulsivity in human
ethamphetamine abusers (Lee et al., 2009). In contrast, PET stud-
es with the dopamine D3 preferring radioligand, [11C]PHNO, which
electively labels dopamine D3 receptors in the substantia nigra,
eport increased nigral dopamine D3 receptor levels in cocaine
nd methamphetamine abuse that was positively correlated with
mpulsiveness and risky decision making (Boileau et al., 2012; Payer
t al., 2014); similarly nigral dopamine D3 receptor levels were
ositively correlated with impulsiveness in pathological gamblers
lthough mean nigral dopamine D3 receptor levels did not differ
rom those in healthy individuals (Boileau et al., 2013).
Rodents fed a high-sugar/high-fat “cafeteria-style” diet become
bese and demonstrate elevated reward thresholds and decreased
Ac dopamine release (Geiger et al., 2009; Johnson and
enny, 2010). In human cocaine-dependent individuals, decreased
opamine release in the anterior caudate and NAc correlated
ith abnormal reward behavior, particularly preference of cocaine
ersus monetary reward (Martinez et al., 2007). The development
f compulsive food intake/binge-eating was accelerated in obese
ats fed a cafeteria-style diet when dorsolateral striatal dopamine
2 receptor levels were decreased using a lentivirus-induced
nockdown approach (Johnson and Kenny, 2010). Similarly,
odents intermittently exposed to a sugar solution develop sugar-
ingeing/addiction but do not become obese (Avena, 2010); these
ugar-bingeing rodents have decreased dorsal striatal dopamine
2-like receptor levels and increased -opioid and dopamine D1-
ike receptor levels in the NAc (Avena, 2010; Colantuoni et al., 2001).
n contrast, genetic upregulation of striatal D2-like receptor levels
n rats trained to self-administer cocaine signiﬁcantly decreases
ocaine self-administration (Thanos et al., 2008). While a cafeteria-
tyle diet may  produce obesity, elevated reward thresholds, and
ecreased dopamine release, it is the development of decreased
opamine D2-like receptor levels, particularly in the dorsolateral
triatum, which appears to lead to compulsive food and drug use.
n animal models, obesity and binge-eating can be produced sepa-havioral Reviews 63 (2016) 223–238
rately and are associated with dissociable changes in dopaminergic
neurotransmission. The function of GABAergic systems within the
NAc has also been demonstrated to play an important role in the
regulation of impulsivity in rats selected for high or low impulsiv-
ity (Caprioli et al., 2014), so it is conceivable that changes in NAc
inhibitory GABA function may  be of importance in the increased
impulsivity in BED by virtue of its role in integrating dopaminergic
neurotransmission.
5.2. Direct and indirect striatonigral pathways
The onset of compulsive behaviors appears to relate to an altered
balance of signaling between the direct and indirect striatonigral
pathways. Dopamine D1 receptors, which are linked to reward, are
largely located in the direct striatonigral pathway; dopamine D2
receptors, which are linked to behavioral ﬂexibility, are largely con-
ﬁned to the indirect pathway (Kenny et al., 2013; Nakanishi et al.,
2014). Hypofunction of the indirect pathway is linked to persever-
ative and compulsive behaviors. In animal models of compulsive
food and drug abuse, as well as in human studies of dopamine D1-
like and D2-like receptors in cocaine-use disorders, both decreased
striatal dopamine D2-like and increased or unchanged levels of
dopamine D1-like receptors are observed, consistent with rela-
tively increased signaling in the direct versus indirect pathways
(Colantuoni et al., 2001; Furlong et al., 2014; Kenny et al., 2013;
Martinez et al., 2004, 2009; Nader et al., 2002; Park et al., 2013).
This imbalance in signaling through the direct and indirect stria-
tonigral pathways associated with decreased dorsolateral striatal
dopamine D2-like receptor levels, in combination with relatively
higher dopamine D1-like receptor signaling, may mediate the
development of compulsive drug and food intake.
While multiple studies in animals demonstrate a role for
dopaminergic neurotransmission in binge-eating behaviors, there
is only a single study of dopaminergic neurotransmission in BED
individuals (Wang et al., 2011). While this study concluded that
obese BED individuals had increased dopamine release in the cau-
date, the study was  limited by the small number of participants
(10 obese BED and 8 obese non-BED individuals) and questions
regarding the confounding effects of methylphenidate, which the
authors reported using to amplify the effects of visual food stimuli
(Wang et al., 2011). [11C]Raclopride positron emission tomo-
graphic (PET) studies were performed in a baseline state, following
visual food stimuli, and following methylphenidate administra-
tion with and without visual food stimuli (Wang et al., 2011).
The difference between dopamine D2-like receptor levels after
methylphenidate administration with food stimuli compared with
baseline levels (without methylphenidate) was  used to estimate
food-stimuli—induced dopamine release (Wang et al., 2011). How-
ever, this comparison confounds the effects of methylphenidate
with food stimuli. This study also reported no difference in baseline
dopamine D2-like receptor levels in striatal subregions between
obese BED and obese non-BED individuals (Wang et al., 2011). This
lack of a signiﬁcant difference in striatal dopamine D2-like receptor
levels, which has been reported in animal models, may  reﬂect a lack
of power due to the small cohort size and/or species differences.
In regard to other neurotransmitters which are of interest in BED,
there has been a single [123I]nor--CIT study of midbrain serotonin
transporters in binge-eating individuals that reported reduced lev-
els (Kuikka et al., 2001). Although [123I]nor--CIT has been used as a
tracer for measurement of serotonin transporters, it has high afﬁn-
ity for the dopamine transporter and midbrain uptake may  reﬂect
levels of both serotonin and dopamine transporters (Bergstrom
et al., 1997; Oya et al., 1999).
Although to date there has been little evidence for a role of
dopaminergic systems in binge-eating in BED individuals, a role
for dopamine systems in the impulsivity and addictive behavior
 Biobehavioral Reviews 63 (2016) 223–238 233
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Table 2
Future areas of research.
• Clinical neuroimaging assessment of the neurochemical basis of BED
•  Utilize PET to examine endogenous DA, NE, 5-HT, opiate and other systems
(e.g., gluamatergic) in the striatum and cortex of obese individuals with
versus without BED and to assess changes in these neurotransmitter
systems after pharmacological pertubations (e.g., following amphetamine
challenge) or behavioral and/or pharmacological interventions (i.e., during
speciﬁc therapies) for BED
• Clinical neuroimaging assessment of cognitive functioning in BED
•  Utilize FMRI to examine functional activity in and connectivity patterns in
regions of the striatum (dorsal versus ventral) and cortex of obese
individuals with versus without BED at baseline and following
pharmacological pertubations or behavioral and/or pharmacological
interventions for BED during the performance of speciﬁc cognitive tasks or
at  rest
• Utilize structural measures (e.g., volumetric and diffusion-weighted MRI) to
examine differences in obese individuals with versus without BED at
baseline and following behavioral and/or pharmacological interventions for
BED
•  Clinical neuroimaging assessment of the role of stress and emotional
regulation in BED
• Utilize FMRI to examine functional activity in regions of the striatum (dorsal
versus ventral) and cortex of obese individuals with versus without BED at
baseline and following pharmacological pertubations or behavioral and/or
pharmacological interventions in response to stress
•  Utilize FMRI to examine functional activity in regions of the striatum (dorsal
versus ventral) and cortex as it relates to stress and emotional regulation in
obese individuals with versus without BED
•  Investigate individual differences as they relate to neurobiological and
clinically relevant measures in BED
•  Assess relationships between individual differences (relating to genetics
[including genome-wide association studies], environmental exposures
[including food availability, poverty, trauma, and other factors],
neurocognition [see above], and other factors [for example, transdiagnostic
measures not listed above that are linked to the RDoC and PhenX
initiatives]) and the development, progression and remission of BED, both
with respect to natural history of BED and interventions targeting BED
5-HT—serotonin; BED—binge-eating disorder; DA—dopamine; FMRI—functional
magnetic resonance imaging; MRI—magnetic resonance imaging;R.M. Kessler et al. / Neuroscience and
s better deﬁned. Impulsivity was correlated with ventral striatal
opamine D2-like receptor levels in rodents (Belin et al., 2008), but
ith ventral midbrain dopamine D2-like receptor levels in humans
Buckholtz et al., 2010). Further studies of dopamine neurotrans-
ission in BED are needed, and aspects of dopamine function
hat have been linked to impulsivity warrant consideration in this
egard (Boileau et al., 2013; Payer et al., 2014; Potenza and Brody,
013). Although an in-depth discussion of the role of dopaminer-
ic transmission in obesity is beyond the scope of this review, it
s worth noting that alterations in dopaminergic tone and pha-
ic dopaminergic signaling have been implicated in mediating
he behavioral characteristics of obesity (Horstmann et al., 2015;
essler et al., 2014).
Alterations in hedonic and reward-related responses and
bserved brain activity patterns in reward-related areas in indi-
iduals with BED share similarities with those in substance-use
isorders and addictions. Additionally, diminished control over
ating and self-sustaining aspects of binge-eating are reminiscent
f the behavioral features of addiction (Bello and Hajnal, 2010;
earhardt et al., 2011; Mathes et al., 2009). The concept, neu-
obiology, and clinical utility of “food addiction” represents an
ngoing area of research (Hebebrand et al., 2014; Meule, 2015;
eule and Gearhardt, 2014; Potenza and Grilo, 2014) that has
een investigated in regard to BED based on the observation that
here are common neurobiological substrates for BED and addiction
Brownell and Gold, 2012; Gearhardt et al., 2011). Although the
opic remains controversial (Avena et al., 2012; Ziauddeen et al.,
012a,b), it is worth noting that BED individuals who  score high
n the Yale Food Addiction Scale (YFAS), which was developed to
ssess the concept of food addiction (Gearhardt et al., 2009), report
ore severe binge-eating pathology than those with lower YFAS
cores, and food addiction as indexed by the YFAS is prominent
mong BED individuals (Gearhardt et al., 2012). Further research is
eeded to clarify more deﬁnitively the relationship between food
ddiction and binge eating in BED.
. Summary
The neurobiological basis of BED is slowly being elucidated.
peciﬁcally, BED individuals exhibit increased impulsivity, com-
ulsivity, and altered reward sensitivity (Galanti et al., 2007;
anwaring et al., 2011; Schag et al., 2013; Wu et al., 2013),
long with enhanced attentional biases directed toward food and
mpaired cognitive function (Boeka and Lokken, 2011; Duchesne
t al., 2010; Mobbs et al., 2011; Schmitz et al., 2014; Svaldi
t al., 2014). As schematically outlined in Fig. 2, the neurobehav-
oral proﬁle observed in BED appears to be subserved by brain
egions, including the ventral striatum, which underlies goal-
eeking behaviors, motivation, and reward sensitivity; the dorsal
triatum, which underlies habitual and compulsive behaviors; the
refrontal cortex, which underlies executive function (Berridge
nd Kringelbach, 2008; Bromberg-Martin et al., 2010; Everitt and
obbins, 2013; Miller and Cohen, 2001); and the insula, which
nderlies interoception, decision-making, taste perception, and
eeding regulation (Naqvi and Bechara, 2010; Small, 2010). These
egions may  relate to BED in a similar manner as they do to addic-
ions and impulse-control disorders (Arnsten, 2011; Greenberg
t al., 2010; Hyman et al., 2006; Li and Sinha, 2008; Morein-Zamir
nd Robbins, 2014).
Although multiple neurotransmitter systems (dopaminergic,
erotonergic, cholinergic, noradrenergic, GABAergic, opioidergic,
nd glutamatergic systems) are likely involved in the neuropatho-
hysiology of BED, human neuroimaging (Balodis et al., 2015) and
nimal (Kenny et al., 2013) studies suggest that altered dopamine
unction is an important contributor to BED and binge-eatingNE—norepinephrine; PET—positron emission tomography; RDoC—Research
Domain Criteria; PhenX: https://www.phenx.org.
behaviors. We  hypothesize that binge-eating reﬂects an imbalance
between the direct striatonigral output pathway (and its associated
D1-like receptors that underlie reward) and the indirect striatopal-
lidal pathway (and its associated D2-like receptors that underlie
behavioral ﬂexibility) (Kenny et al., 2013; Nakanishi et al., 2014).
The putative hypofunction of the indirect pathway, as reﬂected by
the reduced D2-like receptor levels reported in animal models of
binge-eating (Kenny et al., 2013), relative to the direct pathway
may  in part mediate the compulsive eating behaviors seen in BED
(Fig. 3). In animals models of drug abuse, the development of this
imbalance may result from chronically increased dopamine release
(Nakanishi et al., 2014); in animal models of binge-eating behav-
iors, restricted access to highly palatable foods produces similar
patterns of altered dopaminergic neurotransmission (Avena, 2010)
and may  lead to the development of binge-eating behaviors.
There is a currently a paucity of neuroimaging studies of cerebral
neurotransmission in humans with BED and of studies describing
the effects of therapeutic agents on corticostriatal activity in BED
individuals (Balodis et al., 2015). As such, potential future research
directions in this area are summarized in Table 2. In this regard, it
is worth noting that while evidence indicates that stress and emo-
tional regulation may  play a role in BED (Corwin et al., 2011; Gianini
et al., 2013; Gluck et al., 2004; Hilbert et al., 2011; Laessle and
Schulz, 2009; Larsen et al., 2009; Nicholls et al., 2016; Pendleton
234 R.M. Kessler et al. / Neuroscience and Biobehavioral Reviews 63 (2016) 223–238
Fig. 2. Schematic representations of brain circuitry implicated in BED and a proposed neurobiological model with respect to reward/motivation, inhibitory control, and
habitual behavior.
*Denotes data based on animal studies.
Fig. 3. Cortical/basal-ganglionic/thalamic pathways involved in reward-related feeding behaviors. “Normal” reward-related feeding behavior is shown on the left side of
ﬁgure.  The transition to binge-eating behaviors involves a transition from a ventral-striatal reward-based mode of reward-related food consumption to a dorsal-striatal
impulsive/compulsive mode of reward-related food consumption. This adaptive change is proposed to involve decreased cortical inhibition of reward-related food consump-
tion,  decreased reward sensitivity related to decreased striatal dopamine release, and an imbalance in the function of the indirect versus direct striatonigral pathways, which
is  hypothesized to underlie compulsive food intake. The development of decreased striatal dopamine D2-like receptor expression has been associated with hypofunction of
the  indirect pathway, with relative preservation of the direct pathway function associated with dopamine D1-like receptor signaling leading to binge-type eating behaviors.
Red  and green lines indicate inhibitory and excitatory pathways, respectively. The red dotted line indicates reduced activity. Black arrows indicate dopamine-containing
neurons from the substantia nigra/ventral tegmental midbrain nuclei.
PFC—prefrontal cortex; OFC—orbitofrontal cortex; DLC—dorsolateral cortex; insula—insular cortex; D str—dorsal striatum; V str—ventral striatum; D1—dopamine D1-like
receptor; D2—dopamine D2-like receptor; Th—thalamus; Sn VTA—substantia nigra, ventral tegmental area nuclei; GPe—globus pallidus external segment; GPi—globus
pallidus internal segment; STN—subthalamic nucleus.
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t al., 2001; Pinaquy et al., 2003; Rosenberg et al., 2013; Schulz
nd Laessle, 2012), neuroimaging studies in individuals with BED
ave not been conducted that would link altered stress and emo-
ional regulation in individuals with BED to altered brain function.
n conclusion, PET studies of cerebral neurotransmission in BED
ndividuals are needed to more clearly delineate the neurochem-
stry of BED and how pharmacotherapies may  interact with these
eurobiological systems to reduce the symptoms of BED. Concur-
ent fMRI may  provide insight into how neurochemical function
elates to the cognitive processes underlying BED, and the integra-
ion of these approaches into clinical trials will help elucidate the
echanisms of action of speciﬁc interventions for BED.
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